
# Title 42— THE PUBLIC HEALTH AND WELFARE
### CHAPTER 7— SOCIAL SECURITY
#### § 1320f. Establishment of program
##### (d) Timing for initial price applicability year 2026

Notwithstanding the provisions of this part, in the case of initial price applicability year 2026, the following rules shall apply for purposes of implementing the program:

(1) Subsection (b)(3) shall be applied by substituting “ September 1, 2023 ” for “, with respect to each initial price applicability year, February 1 of the year that begins 2 years prior to such year”.

(2) Subsection (b)(4) shall be applied

(A) in subparagraph (A)(ii), by substituting “ October 1, 2023 ” for “February 28 following the selected drug publication date with respect to such selected drug”; and

(B) in subparagraph (B), by substituting “ August 1, 2024 ” for “November 1 of the year that begins 2 years prior to the initial price applicability year”.

(3) Section 1320f–1 of this title shall be applied

(A) in subsection (b)(1)(A), by substituting “during the period beginning on June 1, 2022 , and ending on May 31, 2023 ” for “during the most recent period of 12 months prior to the selected drug publication date (but ending not later than October 31 of the year prior to the year of such drug publication date), with respect to such year, for which data are available”; and

(B) in subsection (d)(1)(A), by substituting “during the period beginning on June 1, 2022 , and ending on May 31, 2023 ” for “during the most recent period for which data are available of at least 12 months prior to the selected drug publication date (but ending no later than October 31 of the year prior to the year of such drug publication date), with respect to such year”. 1

(4) Section 1320f–2(a) of this title shall be applied by substituting “ October 1, 2023 ” for “February 28 following the selected drug publication date with respect to such selected drug”.

(5) Section 1320f–3(b)(2) of this title shall be applied

(A) in subparagraph (A), by substituting “ October 2, 2023 ” for “March 1 of the year of the selected drug publication date, with respect to the selected drug”;

(B) in subparagraph (B), by substituting “ February 1, 2024 ” for “the June 1 following the selected drug publication date”; and

(C) in subparagraph (E), by substituting “ August 1, 2024 ” for “the first day of November following the selected drug publication date, with respect to the initial price applicability year”.

(6) Section 1320f–4(a)(1) of this title shall be applied by substituting “ September 1, 2024 ” for “November 30 of the year that is 2 years prior to such initial price applicability year”.
